Professor Robert Wilson became a consultant at Royal Brompton Hospital in 1989. He has been director of respiratory medicine at the Trust for ten years.
During this time. he has implemented many improvements in patient care. These include:
- expanding the minimal dependency assessment unit
- moving to single beds on the infection ward
- building a new bronchoscopy suite
- developing the role of nurse practitioners.
His most recent role is as the clinical lead of the host defence unit at Royal Brompton Hospital.
In September 2018, Professor Wilson was promoted to Professor of practice (Respiratory medicine) from the National Heart and Lung Institute, Imperial College London - recognising his academic contributions.
Areas of expertise
Professor Wilson's areas of expertise include:
- investigating the body's defences against lung infections
- primary ciliary dyskinesia
- primary immunodeficiency
- non-tuberculous mycobacteria infections
- chronic obstructive pulmonary disease (COPD)
- antibiotic trials
Professor Wilson has lectured for the British and European Thoracic societies, as well as others.
He has travelled the world on lecture tours, visiting China, Mexico and South Africa amongst others. Several pharmaceutical companies also use Professor Wilson as a consultant.
Professor Wilson has written more than 100 peer-reviewed papers and review articles. He has also written several book chapters for various publications.
He sits on the editorial board for the Clinical Pulmonary Medicine journal and co-wrote the Pneumonia Pocketbook.
Other publications include:
Wilson R, "What price clinical innovation?", Health innovations: more for less in healthcare, Churchill N (ed.), The Smith Institute, 2010, pp28-37.
- Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, Wilson R, "Mortality in bronchiectasis: a long term study assessing the factors influencing survival", Eur Respir J, 2009; 34: 843-9.
Wilson R, Jones P, Schaberg T, Arvis P, Duprat-Lomon I, Sagnier PP, "Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis", Thorax 2006; 61: 337-342.
Kunst H, Wickremasinghe M, Wells A, Wilson R, "Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis", Eur Resp J, 2006; 28: 352-7.
Wilson R, Allegra L, Huchon G, Izquierdo JL, Jones P, Schaberg T, Sagnier PP, "Short-term and long-term outcomes of moxifloxacin compared to standard antibiotics in acute exacerbations of chronic bronchitis", Chest 2004; 125: 953-64.